Realizing the promise of cancer predisposition genes
- 15 January 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 505 (7483), 302-308
- https://doi.org/10.1038/nature12981
Abstract
Genes in which germline mutations confer highly or moderately increased risks of cancer are called cancer predisposition genes. More than 100 of these genes have been identified, providing important scientific insights in many areas, particularly the mechanisms of cancer causation. Moreover, clinical utilization of cancer predisposition genes has had a substantial impact on diagnosis, optimized management and prevention of cancer. The recent transformative advances in DNA sequencing hold the promise of many more cancer predisposition gene discoveries, and greater and broader clinical applications. However, there is also considerable potential for incorrect inferences and inappropriate clinical applications. Realizing the promise of cancer predisposition genes for science and medicine will thus require careful navigation.Keywords
This publication has 108 references indexed in Scilit:
- Dyskeratosis congenita as a disorder of telomere maintenanceMutation research. Reviews in mutation research, 2012
- Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 MutationsCell, 2012
- Succinate dehydrogenase – Assembly, regulation and role in human diseaseMitochondrion, 2010
- The inherited genetics of ovarian and endometrial cancerCurrent Opinion in Genetics & Development, 2010
- International network of cancer genome projectsNature, 2010
- Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysisBreast Cancer Research and Treatment, 2010
- Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersAmerican Journal of Human Genetics, 2008
- The Catalogue of Somatic Mutations in Cancer (COSMIC)Current Protocols in Human Genetics, 2008
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- Germline mutations in HRAS proto-oncogene cause Costello syndromeNature Genetics, 2005